Suppr超能文献

皂苷对人腺苷A1受体结合及功能特性的影响。

The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.

作者信息

Cohen F R, Lazareno S, Birdsall N J

机构信息

Division of Physical Biochemistry, National Institute for Medical Research, Mill Hill, London.

出版信息

Br J Pharmacol. 1996 Apr;117(7):1521-9. doi: 10.1111/j.1476-5381.1996.tb15316.x.

Abstract
  1. Experiments with adenosine deaminase suggest that adenosine is present in membrane preparations from CHO cells bearing adenosine A1 receptors. 2. Pretreatment of the membranes (ca 0.6 mg protein ml-1) with the permeabilizing agent saponin (100 micrograms ml-1) or addition of saponin (10 micrograms ml-1) to the membranes (0.02-0.08 mg protein ml-1) in the assay, generates homogeneous low affinity agonist binding curves in the presence of GTP and an increased function, assessed by agonist stimulation of [35S]-GTP gamma S binding. The affinity constants for the binding of an agonist and an antagonist are not affected by this saponin treatment. Saponin facilitates the interaction of guanine nucleotides with receptor G-protein complexes, possibly by removing a permeability barrier to access of G-proteins by GTP. However, adenosine is still present in the binding assays after saponin treatment. 3. The agonist binding properties of the human A1 receptor have been characterized. In saponin pretreated membranes, 80-90% of the A1 receptors are capable of forming agonist-receptor-G protein complexes in the absence of GTP. These complexes have a 300-600 fold higher affinity than uncoupled receptors for N6-cyclohexyladenosine. 4. A very slow component is observed in the association and dissociation kinetics of the agonist [3H]-N6-cyclohexyladenosine ([3H]-CHA) and in the association but not dissociation kinetics of the antagonist [3H]-8-cyclopentyl-1,3-dipropylxanthine ([3H]-DPCPX). The slow association component of [3H]-DPCPX is essentially absent when incubations are carried out in the presence of GTP. The slow dissociation component of [3H]-CHA binding is rapidly disrupted by GTP. 5. It is hypothesized that long-lasting adenosine-receptor-G protein complexes are present in the CHO membrane preparations. The existence of these complexes, resistant to the action of adenosine deaminase but sensitive to GTP, may rationalize the observed kinetics and the increase in 3H-antagonist binding produced by GTP which has been observed in essentially all studies of A1 receptors and has been ascribed previously to precoupling of A1 receptors to G-proteins in the absence of agonists.
摘要
  1. 腺苷脱氨酶实验表明,在表达腺苷A1受体的CHO细胞膜制剂中存在腺苷。2. 用通透剂皂角苷(100微克/毫升)预处理膜(约0.6毫克蛋白质/毫升),或在测定中向膜(0.02 - 0.08毫克蛋白质/毫升)中添加皂角苷(10微克/毫升),在存在GTP的情况下会产生均匀的低亲和力激动剂结合曲线,并且通过激动剂刺激[35S]-GTPγS结合评估其功能增强。激动剂和拮抗剂结合的亲和力常数不受这种皂角苷处理的影响。皂角苷可能通过消除GTP接近G蛋白的通透性屏障,促进鸟嘌呤核苷酸与受体G蛋白复合物的相互作用。然而,皂角苷处理后结合测定中仍存在腺苷。3. 已对人A1受体的激动剂结合特性进行了表征。在经皂角苷预处理的膜中,80 - 90%的A1受体在不存在GTP的情况下能够形成激动剂 - 受体 - G蛋白复合物。这些复合物对N6 - 环己基腺苷的亲和力比未偶联的受体高300 - 600倍。4. 在激动剂[3H]-N6 - 环己基腺苷([3H]-CHA)的结合和解离动力学中观察到一个非常缓慢的成分,而在拮抗剂[3H]-8 - 环戊基 - 1,3 - 二丙基黄嘌呤([3H]-DPCPX)的结合动力学中观察到缓慢成分,但解离动力学中未观察到。当在存在GTP的情况下进行孵育时,[3H]-DPCPX的缓慢结合成分基本不存在。[3H]-CHA结合的缓慢解离成分会被GTP迅速破坏。5. 据推测,CHO细胞膜制剂中存在持久的腺苷 - 受体 - G蛋白复合物。这些复合物的存在,对腺苷脱氨酶的作用具有抗性但对GTP敏感,这可能解释了观察到的动力学以及在基本上所有A1受体研究中都观察到的GTP导致的3H - 拮抗剂结合增加,这一现象先前被归因于在不存在激动剂的情况下A1受体与G蛋白的预偶联。

相似文献

引用本文的文献

6
SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.SB265610 是一种人源 CXCR2 受体的变构、反向激动剂。
Br J Pharmacol. 2009 Sep;158(1):328-38. doi: 10.1111/j.1476-5381.2009.00182.x. Epub 2009 Apr 24.
8
New selective ligands of human cloned melatonin MT1 and MT2 receptors.人克隆褪黑素MT1和MT2受体的新型选择性配体。
Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):553-61. doi: 10.1007/s00210-003-0751-2. Epub 2003 May 23.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验